BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2839669)

  • 1. Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system.
    Chaput Y; de Montigny C
    J Pharmacol Exp Ther; 1988 Jul; 246(1):359-70. PubMed ID: 2839669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
    Chaput Y; de Montigny C; Blier P
    Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.
    Chaput Y; Lesieur P; de Montigny C
    Synapse; 1990; 6(4):328-37. PubMed ID: 1962911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe.
    PiƱeyro G; Deveault L; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):119-25. PubMed ID: 7770094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
    Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
    Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
    Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.
    Blier P; de Montigny C
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):13S-20S. PubMed ID: 1973935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA; Motevalian M; Whalley ET
    Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
    Haddjeri N; De Montigny C; Curet O; Blier P
    Eur J Pharmacol; 1998 Feb; 343(2-3):179-92. PubMed ID: 9570466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
    Godbout R; Chaput Y; Blier P; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):679-90. PubMed ID: 1681446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997.
    Hirose A; Sasa M; Akaike A; Takaori S
    Neuropharmacology; 1990 Feb; 29(2):93-101. PubMed ID: 1970426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.
    Blier P; Steinberg S; Chaput Y; de Montigny C
    Can J Physiol Pharmacol; 1989 Feb; 67(2):98-105. PubMed ID: 2523754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine receptors modulate 5-hydroxytryptamine neurotransmission in the rat hippocampus: in vivo electrophysiological evidence.
    Lista A; Blier P; de Montigny C
    J Pharmacol Exp Ther; 1990 Jul; 254(1):318-23. PubMed ID: 2164098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
    Blier P; Lista A; De Montigny C
    J Pharmacol Exp Ther; 1993 Apr; 265(1):7-15. PubMed ID: 8474032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.